Cargando…
Ipilimumab/nivolumab: Myocarditis-myositis overlap syndrome and ocular myositis: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644410/ http://dx.doi.org/10.1007/s40278-020-84941-0 |
Ejemplares similares
-
Fulminant myocarditis with myositis of ocular and respiratory muscles
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020) -
Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023) -
BBV-152: Myocarditis and myositis: case report
Publicado: (2022) -
Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021) -
Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma
por: Fazel, Mahdieh, et al.
Publicado: (2019)